Chemoinformaics analysis of Isorhynchophylline
Molecular Weight | 384.476 | nRot | 4 |
Heavy Atom Molecular Weight | 356.252 | nRig | 23 |
Exact Molecular Weight | 384.205 | nRing | 4 |
Solubility: LogS | -3.918 | nHRing | 3 |
Solubility: LogP | 2.93 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 22 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 5 | APOL | 60.8182 |
nHD | 1 | BPOL | 35.5778 |
QED | 0.491 |
Synth | 4.656 |
Natural Product Likeliness | 1.881 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.558 |
Pgp-sub | 0.507 |
HIA | 0.005 |
CACO-2 | -4.579 |
MDCK | 0.0000281 |
BBB | 0.994 |
PPB | 0.537252 |
VDSS | 1.134 |
FU | 0.361895 |
CYP1A2-inh | 0.109 |
CYP1A2-sub | 0.765 |
CYP2c19-inh | 0.632 |
CYP2c19-sub | 0.948 |
CYP2c9-inh | 0.657 |
CYP2c9-sub | 0.097 |
CYP2d6-inh | 0.918 |
CYP2d6-sub | 0.638 |
CYP3a4-inh | 0.916 |
CYP3a4-sub | 0.922 |
CL | 11.123 |
T12 | 0.261 |
hERG | 0.756 |
Ames | 0.289 |
ROA | 0.934 |
SkinSen | 0.779 |
Carcinogencity | 0.933 |
EI | 0.01 |
Respiratory | 0.961 |
NR-Aromatase | 0.213 |
Antiviral | No |
Prediction | 0.61354 |